Fast-track HRA review of COVID-19 studies
The Health Research Authority (HRA) is working with the rest of the research system to provide a coordinated process so that COVID-19 research can progress quickly, using a fast-track review process with bespoke advice and support for researchers.
The average review timeline is 5 days, with many completed within 24 to 72 hours.
HRA have updated the information on their website about the fast-track review process, guidance for researchers, sites and sponsors, guidance about using confidential patient data without consent and information about how it is handling other types of research.
This review takes place in parallel with the Chief Medical Officer’s prioritisation process for COVID studies.
To ensure that information about COVID-19 related research is made public as quickly as possible, summary information about each COVID-19 research project is available on the HRA website.
If you would like more information about NIHR Cambridge BRC, please contact us.